World Oncology Cell Therapy Congress 2023

The World Oncology Cell Therapy Congress

The 7th Annual World Oncology Cell Therapy Congress Returns April 25-26 2023

Download the agenda
Boston, USA
25-26 April, 2023

“It’s really fascinating what’s happening in cell therapy, so having a concentrated amount of people here talking about NK Cells, the manufacturing, everything from the soup to the nuts of actual cell therapy has been incredible.”

Bryan Kobel, Chief Executive Officer, TC Biopharm

ATTENDEE TESTIMONIALS

WHO WILL YOU MEET?

Why Attend

The World Oncology Cell Therapy Congress is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation. 

For 2023, we have revamped and repositioned the schedule to reflect the dynamic research environment of the cell therapy field. 

Enjoy an exclusive pre-event evening networking session centred around overcoming barriers to patient access and facilitating clinical distribution of transformative cell therapy products. 

Our on-stage talks, panels and Q&As will come under the following themes:  

• Breakthroughs and Pipeline Advancements 

• New Cell Therapy Platforms and Enabling Technologies 

• Manufacturing at Scale and Commercialization 

• Pre-event evening expanding into Cell Therapy Access 

Speakers

 

Agi Hamburger

VP Drug Discovery
A2 Biotherapeutics

Agi Hamburger

VP Drug Discovery
A2 Biotherapeutics

Agi Hamburger

VP Drug Discovery
A2 Biotherapeutics
 

Albert Ribickas

Manager Blood and Marrow Transplant Laboratory
Moffitt Cancer Center

Albert Ribickas

Manager Blood and Marrow Transplant Laboratory
Moffitt Cancer Center

Albert Ribickas

Manager Blood and Marrow Transplant Laboratory
Moffitt Cancer Center
 

Alexandra Lisi

Senior Field Application Scientist
Thermo Fisher Scientific

Alexandra Lisi

Senior Field Application Scientist
Thermo Fisher Scientific

Alexandra Lisi

Senior Field Application Scientist
Thermo Fisher Scientific
 

Chaozhong Zou

CTO, Cell Therapy
Simnova Biotherapeutics aplan

Chaozhong Zou

CTO, Cell Therapy
Simnova Biotherapeutics aplan

Chaozhong Zou

CTO, Cell Therapy
Simnova Biotherapeutics aplan
 

Dan Shelly

VP BD and Alliances
Prescient Therapeutics

Dan Shelly

VP BD and Alliances
Prescient Therapeutics

Dan Shelly

VP BD and Alliances
Prescient Therapeutics
 

Deyaa Adib

CMO
Triumvira Immunologics

Deyaa Adib

CMO
Triumvira Immunologics

Deyaa Adib

CMO
Triumvira Immunologics
 

Eric Halioua

President and CEO
PDC*line pharma

Eric Halioua

President and CEO
PDC*line pharma

Eric Halioua

President and CEO
PDC*line pharma
 

Eytan Breman

R&D Director
Celyad Oncology

Eytan Breman

R&D Director
Celyad Oncology

Eytan Breman

R&D Director
Celyad Oncology
 

Frank Borriello

CEO
Alloplex Biotherapeutics

Frank Borriello

CEO
Alloplex Biotherapeutics

Frank Borriello

CEO
Alloplex Biotherapeutics
 

Gavin MacBeath

President and CEO
Tscan Therapeutics

Gavin MacBeath

President and CEO
Tscan Therapeutics

Gavin MacBeath

President and CEO
Tscan Therapeutics
 

Geoffrey Hodge

CEO
SOTIO Bio

Geoffrey Hodge

CEO
SOTIO Bio

Geoffrey Hodge

CEO
SOTIO Bio
 

John Maher

CSO
Leucid Bio

John Maher

CSO
Leucid Bio

John Maher

CSO
Leucid Bio
 

John Rossi

VP Translational Medicine
Syncopation Life Sciences

John Rossi

VP Translational Medicine
Syncopation Life Sciences

John Rossi

VP Translational Medicine
Syncopation Life Sciences
 

Jonathan Benjamin

Chief Medical Officer
Immpact Bio

Jonathan Benjamin

Chief Medical Officer
Immpact Bio

Jonathan Benjamin

Chief Medical Officer
Immpact Bio
 

Khalid Shah

Professor
Harvard Medical School

Khalid Shah

Professor
Harvard Medical School

Khalid Shah

Professor
Harvard Medical School
 

Leah Sibener

VP of Therapeutic Discovery and Co-founder
3T Biosciences

Leah Sibener

VP of Therapeutic Discovery and Co-founder
3T Biosciences

Leah Sibener

VP of Therapeutic Discovery and Co-founder
3T Biosciences
 

Levi Gray-Rupp

Director, Discovery Immunology
Arsenal Bio

Levi Gray-Rupp

Director, Discovery Immunology
Arsenal Bio

Levi Gray-Rupp

Director, Discovery Immunology
Arsenal Bio
 

Marco Ruella

Professor
University of Pennsylvania

Marco Ruella

Professor
University of Pennsylvania

Marco Ruella

Professor
University of Pennsylvania
 

Mark Shlomchik

CSO and Co-founder
BlueSphere Bio

Mark Shlomchik

CSO and Co-founder
BlueSphere Bio

Mark Shlomchik

CSO and Co-founder
BlueSphere Bio
 

Mark Throsby

COO/CSO
Gadeta

Mark Throsby

COO/CSO
Gadeta

Mark Throsby

COO/CSO
Gadeta
 

Matt Britz

Chief Operating Officer
AffyImmune

Matt Britz

Chief Operating Officer
AffyImmune

Matt Britz

Chief Operating Officer
AffyImmune
 

Michael Singer

CSO
Cartesian Therapeutics

Michael Singer

CSO
Cartesian Therapeutics

Michael Singer

CSO
Cartesian Therapeutics
 

Peter Andersen

CEO
Vita Therapeutics

Peter Andersen

CEO
Vita Therapeutics

Peter Andersen

CEO
Vita Therapeutics
 

Rachel Lynn

Associate Director, Research
Lyell Immunopharma

Rachel Lynn

Associate Director, Research
Lyell Immunopharma

Rachel Lynn

Associate Director, Research
Lyell Immunopharma
 

Rajesh Krishnan

CTO
Oncternal

Rajesh Krishnan

CTO
Oncternal

Rajesh Krishnan

CTO
Oncternal
 

Raphaël Ognar

CEO and Co-founder
NKILT Therapeutics

Raphaël Ognar

CEO and Co-founder
NKILT Therapeutics

Raphaël Ognar

CEO and Co-founder
NKILT Therapeutics
 

Raymond Luke

Director, MSAT
Verismo Therapeutics

Raymond Luke

Director, MSAT
Verismo Therapeutics

Raymond Luke

Director, MSAT
Verismo Therapeutics
 

Robert Mabry

CSO
Orna Therapeutics

Robert Mabry

CSO
Orna Therapeutics

Robert Mabry

CSO
Orna Therapeutics
 

Robert Richards

Administrative Director of Cell Therapy and Transplant
University of Pennsylvania

Robert Richards

Administrative Director of Cell Therapy and Transplant
University of Pennsylvania

Robert Richards

Administrative Director of Cell Therapy and Transplant
University of Pennsylvania
 

Saba Ghassemi

Research Assistant Professor
University of Pennsylvania Medicine

Saba Ghassemi

Research Assistant Professor
University of Pennsylvania Medicine

Saba Ghassemi

Research Assistant Professor
University of Pennsylvania Medicine
 

Sareina Wu

Founder and CSO
Genome Frontier

Sareina Wu

Founder and CSO
Genome Frontier

Sareina Wu

Founder and CSO
Genome Frontier
 

Seshu Tummala

VP CMC, Technical Operations
MANA Therapeutics

Seshu Tummala

VP CMC, Technical Operations
MANA Therapeutics

Seshu Tummala

VP CMC, Technical Operations
MANA Therapeutics
 

Stefanie Mandl

SVP Research
PACT Pharma

Stefanie Mandl

SVP Research
PACT Pharma

Stefanie Mandl

SVP Research
PACT Pharma
 

Steven Katz

Chief Medical Officer
Trisalus Life Sciences

Steven Katz

Chief Medical Officer
Trisalus Life Sciences

Steven Katz

Chief Medical Officer
Trisalus Life Sciences
 

Sumant Ramachandra

CEO
IMMPACT Bio

Sumant Ramachandra

CEO
IMMPACT Bio

Sumant Ramachandra

CEO
IMMPACT Bio
 

Sylvain Roy

CTO
IMMPACT Bio

Sylvain Roy

CTO
IMMPACT Bio

Sylvain Roy

CTO
IMMPACT Bio
 

Tomoki Otani

Director, Business Development
Logomix

Dr. Tomoki Otani is business development lead of Logomix, a synthetic biology company enabling MB-scale genomic engineering in mammalian cells. Combining careers in research science and a top-tier management consulting firm, McKinsey & Company, Tomoki’s expertise spans from stem cell biology, ophthalmology and genomic engineering to business growth strategy and drug launch excellence.

Tomoki Otani

Director, Business Development
Logomix

Tomoki Otani

Director, Business Development
Logomix

Dr. Tomoki Otani is business development lead of Logomix, a synthetic biology company enabling MB-scale genomic engineering in mammalian cells. Combining careers in research science and a top-tier management consulting firm, McKinsey & Company, Tomoki’s expertise spans from stem cell biology, ophthalmology and genomic engineering to business growth strategy and drug launch excellence.

 

Vicki Plaks

Senior Director, Cell Therapy, Oncology Discovery
Abbvie

Vicki Plaks

Senior Director, Cell Therapy, Oncology Discovery
Abbvie

Vicki Plaks

Senior Director, Cell Therapy, Oncology Discovery
Abbvie
 

Yan Chen

Founder and CEO
Elpis Biopharm

Yan Chen

Founder and CEO
Elpis Biopharm

Yan Chen

Founder and CEO
Elpis Biopharm

Venue

Hyatt Regency Boston, One Avenue De Lafayette, Boston, MA 02111

Discounted rooms available to attendees here.

DOWNLOAD THE AGENDA

Download the revamped agenda to discover more, including:

  • The CAR-T Party (Day 1 Evening)
  • Biotech Showcase (Day 2 AM)
  • Roundtable Discussions
  • 3 Tracks for Onstage Presentations: A) Breakthroughs and Pipeline Advancements B) New Cell Therapy Platforms and Enabling Technologies C) Manufacturing at Scale and Commercialization

AGENDA

BIOTECH SHOWCASE

The Biotech Showcase is the perfect way for you to share details of the exciting research you’re working on, and what’s coming soon for you, with our audience of cell therapy drug developers, solution providers and investors.

Over 90 minutes, we’ll invite 9 up-and-coming companies to present on the main stage at the event. Does that sound like you? You can apply below for the chance to be one of those selected. Please note that speaking slots are limited.

Showcase submission application deadline is 7pm (EST) on Thursday March 30.

Applications received after this time may not be accepted, so don’t miss out – apply now.

Apply now

2023 Partners

Gold Partners

Silver Sponsors

Exhibitors

Event Partner

2023 Media Partners

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. From presenting your expertize on the main stage to hosting the infamous CAR-T Party. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

Discuss your objectives with James Tappenden, Sales Director[email protected] or Oleksiy Ihnatenko, Commercial Partnerships[email protected].

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact Laura Hobson, Senior Marketing Manager; [email protected]

DOWNLOAD THE AGENDA               DOWNLOAD SPONSORSHIP PROSPECTUS

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Registration ends in

Saturday, March 25, 2023 to Wednesday, April 26, 2023
Tier 1 - Academics
$1499
Researchers working solely at an academic institute or hospital/clinic/surgery
Saturday, March 25, 2023 to Wednesday, April 26, 2023
Tier 2 - Small Biotech
$2099
Less than 20 employees - lead candidate in phase I/II or before
Saturday, March 25, 2023 to Wednesday, April 26, 2023
Tier 3 - Biopharma
$2999
Must have a publicly available active pipeline and not provide services to other drug developers/academics
Saturday, March 25, 2023 to Wednesday, April 26, 2023
Tier 4 - Industry/Service Provider
$3999
Preparing registration...

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 5% Off
Book a Team of 5+ - Save an Additional 10% Off
Book a Team of 10+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

Terms & Conditions

In the event that Kisaco Research postpones an event for any reason or changes the event format to ‘virtual event’, any in-person registrations for this event will be automatically transferred to the virtual registration package. The delegate will receive a credit note for the difference in ticket value from the fee paid. You may use this credit for another Kisaco Research event to be mutually agreed with Kisaco Research, which must occur within 12 months from the date of the event which the delegate had originally registered for.

Resources

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us